Anish Sharda, MD, MPH
Assistant ProfessorCards
About
Research
Publications
2023
Insights into platelet pharmacology from a cryo-EM structure of the ABCC4 transporter
Sharda A, Gu S, Hwa J. Insights into platelet pharmacology from a cryo-EM structure of the ABCC4 transporter. Nature Cardiovascular Research 2023, 2: 606-608. PMID: 37655224, PMCID: PMC10470688, DOI: 10.1038/s44161-023-00293-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2022
Aspirin thromboprophylaxis in joint replacement surgery.
Sharda AV, Fatovic K, Bauer KA. Aspirin thromboprophylaxis in joint replacement surgery. Res Pract Thromb Haemost 2022, 6: e12649. PMID: 35106432, DOI: 10.1002/rth2.12649.Peer-Reviewed Original Research
2021
Circulating Protein Disulfide Isomerase Is Associated with Increased Risk of Thrombosis in JAK2-Mutated Myeloproliferative Neoplasms.
Sharda AV, Bogue T, Barr A, Mendez LM, Flaumenhaft R, Zwicker JI. Circulating Protein Disulfide Isomerase Is Associated with Increased Risk of Thrombosis in JAK2-Mutated Myeloproliferative Neoplasms. Clin Cancer Res 2021, 27: 5708-5717. PMID: 34400417, DOI: 10.1158/1078-0432.CCR-21-1140.Peer-Reviewed Original ResearchAnti-thrombotic effects mediated by dihydromyricetin involve both platelet inhibition and endothelial protection.
Chen S, Lv K, Sharda A, Deng J, Zeng W, Zhang C, Hu Q, Jin P, Yao G, Xu X, Ming Z, Fang C. Anti-thrombotic effects mediated by dihydromyricetin involve both platelet inhibition and endothelial protection. Pharmacol Res 2021, 167: 105540. PMID: 33711433, DOI: 10.1016/j.phrs.2021.105540.Peer-Reviewed Original Research
2020
VWF maturation and release are controlled by 2 regulators of Weibel-Palade body biogenesis: exocyst and BLOC-2.
Sharda AV, Barr AM, Harrison JA, Wilkie AR, Fang C, Mendez LM, Ghiran IC, Italiano JE, Flaumenhaft R. VWF maturation and release are controlled by 2 regulators of Weibel-Palade body biogenesis: exocyst and BLOC-2. Blood 2020, 136: 2824-2837. PMID: 32614949, DOI: 10.1182/blood.2020005300.Peer-Reviewed Original ResearchDose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial.
Zwicker JI, Roopkumar J, Puligandla M, Schlechter BL, Sharda AV, Peereboom D, Joyce R, Bockorny B, Neuberg D, Bauer KA, Khorana AA. Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial. Blood Adv 2020, 4: 2254-2260. PMID: 32442298, DOI: 10.1182/bloodadvances.2020001804.Peer-Reviewed Original Research
2019
Platelet Secretion
Robert Flaumenhaft, Anish Sharda, 19 - Platelet Secretion, Editor(s): Alan D. Michelson, Platelets (Fourth Edition), Academic Press, 2019, Pages 349-370, ISBN 9780128134566,Chapters
2018
Regulatory role of thiol isomerases in thrombus formation.
Sharda A, Furie B. Regulatory role of thiol isomerases in thrombus formation. Expert Rev Hematol 2018, 11: 437-448. PMID: 29542339, DOI: 10.1080/17474086.2018.1452612.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThe life cycle of platelet granules.
Sharda A, Flaumenhaft R. The life cycle of platelet granules. F1000Res 2018, 7: 236. PMID: 29560259, DOI: 10.12688/f1000research.13283.1.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2017
Detection of membrane-bound and soluble antigens by magnetic levitation.
Andersen MS, Howard E, Lu S, Richard M, Gregory M, Ogembo G, Mazor O, Gorelik P, Shapiro NI, Sharda AV, Ghiran I. Detection of membrane-bound and soluble antigens by magnetic levitation. Lab Chip 2017, 17: 3462-3473. PMID: 28905952, DOI: 10.1039/c7lc00402h.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Clinical Care
Overview
Anish Sharda, MBBS (a medical degree awarded outside of the U.S.), is a physician-scientist and an assistant professor of medicine at Yale School of Medicine. Dr Sharda is a classical hematologist who specializes in the treatment of bleeding, clotting, and platelet disorders.
Dr. Sharda runs a National Institutes of Health-funded laboratory that conducts research in bleeding and clotting disorders, specifically von Willebrand disease. His research aims to improve understanding of this bleeding disorder as well as discover novel treatments.
Dr. Sharda completed his medical training at B.P. Koirala Institute of Health Sciences in Nepal, followed by a residency in internal medicine at the University of Minnesota Medical Center. He then pursued a clinical and research fellowship in hematology and oncology at Beth Israel Deaconess Medical Center and Harvard Medical School, where he was a faculty member until 2022.
Clinical Specialties
Fact Sheets
Bleeding Disorders
Learn More on Yale MedicineBlood Clots in Veins, Heart and Lungs
Learn More on Yale Medicine
Yale Medicine News
News & Links
News
- January 08, 2025
Smilow Shares with Primary Care: Benign Hematology and Elevated Blood Counts
- February 15, 2024
Educational Exchange Brings Ugandan Hematologist Dr. Christine Sekaggya-Wiltshire to Yale School of Medicine
- December 08, 2023
New Research Reveals How Modifying a Key Molecular Regulator Could Improve the Treatment of von Willebrand Disease
- November 28, 2023
Yale Cancer Center Experts Present New Research at Hematology Annual Meeting
Get In Touch
Contacts
Hematology
300 George St
New Haven, Connecticut 06511
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.